Seeing Is Believing
Healthcare - Sector
ImmunoGen's activity chart (see below) currently has 104 price targets and 106 ratings on display.
Analysts average stock forecasts to be materialized ratio is 94.96% with an average time for these price targets to be met of 633.76 days.
Most recent stock forecast was given by from MIZUHO on 04-Dec-2023. First documented stock forecast 06-Aug-2012.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Dec-2023
$31
$-0.23 (-0.74%)
$31
2 years 9 months 10 days ago
(04-Dec-2023)
4/4 (100%)
$1.78 (6.09%)
887
Buy Since 09-Sep-2022
$31
$-0.23 (-0.74%)
$27
2 years 9 months 10 days ago
(04-Dec-2023)
4/4 (100%)
$1.78 (6.09%)
148
Buy Since 16-Nov-2022
$31
$-0.23 (-0.74%)
$26
2 years 9 months 13 days ago
(01-Dec-2023)
4/4 (100%)
$1.68 (5.73%)
114
Buy Since 04-Mar-2019
$25
$-6.23 (-19.95%)
2 years 9 months 13 days ago
(01-Dec-2023)
2/3 (66.67%)
$-4.32 (-14.73%)
1387
Buy Since 01-Dec-2023
$31
$-0.23 (-0.74%)
2 years 9 months 13 days ago
(01-Dec-2023)
2/2 (100%)
$1.68 (5.73%)
294
What is IMGN (ImmunoGen) average time for price targets to be met?
Which analyst most recently updated their price target on IMGN (ImmunoGen)?
Which analyst has the most public recommendations on IMGN (ImmunoGen)?
Which analyst is the currently most bullish on IMGN (ImmunoGen)?
Which analyst is the currently most reserved on IMGN (ImmunoGen)?